Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Trillium Therapeutics Inc (TRIL)  
$18.44 0.00 (0.00%) as of 4:30 Tue 11/16


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 100,180,000
Market Cap: 1.85(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.44 - $18.44
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 48
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Petrova Penka Chief Development Officer   •       –      –    2021-02-09 4 OE $9.62 $4,888 D/D 508 508     -
   Uger Robert Chief Scientific Officer   •       –      –    2021-02-08 4 AS $12.65 $83,022 D/D (6,563) 0 -28%     
   Uger Robert Chief Scientific Officer   •       –      –    2021-02-08 4 OE $0.30 $10,751 D/D 6,563 6,563     -
   Petrova Penka Chief Development Officer   •       –      –    2021-02-08 4 AS $12.65 $67,197 D/D (5,312) 0 -28%     
   Petrova Penka Chief Development Officer   •       –      –    2021-02-08 4 OE $0.30 $9,435 D/D 5,312 5,312     -
   Skvarka Jan President and CEO   •       •      –    2021-01-14 4 AS $15.03 $294,279 D/D (19,581) 0 -48%     
   Skvarka Jan President and CEO   •       •      –    2021-01-14 4 OE $0.43 $8,371 D/D 19,581 19,581     -
   Skvarka Jan President and CEO   •       •      –    2021-01-13 4 AS $15.04 $81,508 D/D (5,419) 0 -48%     
   Skvarka Jan President and CEO   •       •      –    2021-01-13 4 OE $0.42 $2,302 D/D 5,419 5,419     -
   Uger Robert Chief Scientific Officer   •       –      –    2021-01-11 4 AS $15.20 $8,879 D/D (584) 0 -41%     
   Uger Robert Chief Scientific Officer   •       –      –    2021-01-11 4 OE $9.57 $5,587 D/D 584 584     -
   Petrova Penka Chief Development Officer   •       –      –    2021-01-11 4 AS $15.21 $7,725 D/D (508) 0 -41%     
   Petrova Penka Chief Development Officer   •       –      –    2021-01-11 4 OE $9.57 $4,860 D/D 508 508     -
   Parsons James T. Chief Financial Officer   •       –      –    2021-01-08 4 AS $15.79 $134,271 D/D (8,505) 0 -45%     
   Parsons James T. Chief Financial Officer   •       –      –    2021-01-08 4 OE $7.24 $61,616 D/D 8,505 8,505     -
   Petrova Penka Chief Development Officer   •       –      –    2021-01-08 4 AS $15.50 $40,365 D/D (2,604) 0 -45%     
   Petrova Penka Chief Development Officer   •       –      –    2021-01-08 4 OE $3.33 $8,674 D/D 2,604 2,604     -
   Uger Robert Chief Scientific Officer   •       –      –    2021-01-08 4 AS $15.51 $133,806 D/D (8,517) 0 -45%     
   Uger Robert Chief Scientific Officer   •       –      –    2021-01-08 4 OE $3.33 $71,365 D/D 8,517 2,917     -
   Uger Robert Chief Scientific Officer   •       –      –    2021-01-07 4 AS $14.75 $53,782 D/D (3,646) 0 -43%     
   Uger Robert Chief Scientific Officer   •       –      –    2021-01-07 4 OE $0.30 $1,089 D/D 3,646 3,646     -
   Petrova Penka Chief Development Officer   •       –      –    2021-01-07 4 AS $14.71 $39,843 D/D (2,708) 0 -43%     
   Petrova Penka Chief Development Officer   •       –      –    2021-01-07 4 OE $0.30 $809 D/D 2,708 2,708     -

  48 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed